Bildkälla: Stockfoto

Saniona: Comment on Update from Mexico (tesofensine)- Redeye

Redeye provides a comment on the regulatory news from Mexico regarding tesofensine. We emphasize that tesofensine-Mexico is not core in Saniona's equity story. Based on this news per se, yesterday's drop in the stock price strikes us as an overreaction.

Redeye provides a comment on the regulatory news from Mexico regarding tesofensine. We emphasize that tesofensine-Mexico is not core in Saniona's equity story. Based on this news per se, yesterday's drop in the stock price strikes us as an overreaction.
Börsvärldens nyhetsbrev
ANNONSER